Clinical trial
Open-label Follow-up Study of the VIPES Study to Evaluate Long-term Efficacy and Safety of the Viaskin Peanut
NCT01955109 is registered in ClinicalTrials.gov with DBV Technologies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-label Follow-up Study of the VIPES Study to Evaluate Long-term Efficacy and Safety of the Viaskin Peanut
- Lead sponsor
- DBV Technologies
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2013
- Completion date
- September 30, 2016
- Enrollment
- 171 (actual)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.
peanut allergy